Author

Christopher M. Mahaffey

Observed name: Christopher M Mahaffey

Observed institutions: University of California, Merced, University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, University of California, Davis

OpenAlex ID: A5111735860

Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation

2007 · Christopher M. Mahaffey, Angela M. Davies, et al. · Clinical Lung Cancer · 77

Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma

2009 · Christopher M. Mahaffey, Hongqiao Zhang, et al. · Free Radical Biology and Medicine · 64

Dual Blockade of PKA and NF–κB Inhibits H2 Relaxin-Mediated Castrate-Resistant Growth of Prostate Cancer Sublines and Induces Apoptosis

2011 · Ruth L. Vinall, Christopher M. Mahaffey, et al. · Hormones and Cancer · 37

Aberrant Regulation of the MRP3 Gene in Non-small Cell Lung Carcinoma

2011 · Christopher M. Mahaffey, Nichole C. Mahaffey, et al. · Journal of Thoracic Oncology · 16

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

2011 · Shiloh M Martin, Eric Churchill, et al. · Journal of Hematology & Oncology · 6

Enhancing the anticancer activity of paclitaxel through cyclin-dependent kinase inhibition

2004 · Philip C. Mack, Christopher M. Mahaffey, et al. · Cancer Research · 1

Multidrug resistant protein-three gene regulation

2010 · Christopher M. Mahaffey · eScholarship (California Digital Library)

Works count: 8

Citation count: 201

H-index: 5

I10-index: 4